Youssef Michael, Tandon Parul, Jones Tyrel, Srikanth Varun, Targownik Laura
Division of Internal Medicine, University of Toronto, Toronto, ON, Canada.
Division of Gastroenterology and Hepatology, University of Toronto, Toronto, ON, Canada.
Dig Dis Sci. 2025 Mar;70(3):1016-1033. doi: 10.1007/s10620-024-08801-2. Epub 2025 Jan 22.
The care of inflammatory bowel disease (IBD) requires special attention among immigrants due to different disease incidence, phenotype, and risk profiles. We aimed to highlight key themes among existing literature to inform equitable care in all immigrants living with IBD.
A systematic literature search was conducted in MEDLINE, EMBASE, the Cochrane library, Scopus, and ProQuest from inception to February 2023 to identify studies capturing the care of IBD among immigrants who moved from one country to another, irrespective of the timing of IBD diagnosis. Studies on immigrant children and children of immigrants were also included. We reported qualitative and quantitative data as reported in each individual study, and where applicable, we noted comparisons between immigrants and non-immigrants, defined as natives of the adopted country.
This review included 50 eligible studies. 12/19 (63.1%) studies reported lower incidence of IBD among immigrants, although rates increased from first- to second-generation immigrants in five studies. Most immigrants had significant changes in their diet after immigration, and their gut microbiota was different compared to non-immigrants. Immigrants had different environmental exposures and in certain populations, more severe IBD phenotypes and extra-intestinal manifestations (EIMs). Medical and surgical treatments were lower among immigrants in certain regions, although they had appropriate healthcare utilization and similar hospitalization rates compared to non-immigrants.
IBD care among immigrants is unique due to their different risk profiles and disease phenotypes, and the potential barriers with healthcare access. Understanding IBD among immigrants is key to ensure equitable care in this unique population.
由于炎症性肠病(IBD)在移民中的发病率、表型和风险特征不同,对其护理需要特别关注。我们旨在突出现有文献中的关键主题,为所有患有IBD的移民提供公平的护理提供参考。
从数据库建立至2023年2月,在MEDLINE、EMBASE、Cochrane图书馆、Scopus和ProQuest中进行了系统的文献检索,以识别有关从一个国家迁移到另一个国家的移民中IBD护理的研究,无论IBD诊断的时间如何。关于移民儿童和移民子女的研究也包括在内。我们按照每项独立研究报告的内容汇报定性和定量数据,适当时,我们指出了移民与非移民(定义为移入国的本地人)之间的比较。
本综述纳入了50项符合条件的研究。12/19(63.1%)的研究报告称移民中IBD的发病率较低,不过在五项研究中,发病率从第一代移民到第二代移民有所上升。大多数移民在移民后饮食发生了显著变化,与非移民相比,他们的肠道微生物群也有所不同。移民有不同的环境暴露情况,在某些人群中,IBD表型和肠外表现(EIMs)更为严重。在某些地区,移民接受的药物和手术治疗较少,不过与非移民相比,他们有适当的医疗保健利用率和相似的住院率。
由于移民的风险特征和疾病表型不同,以及获得医疗保健方面可能存在的障碍,移民中的IBD护理具有独特性。了解移民中的IBD是确保为这一独特人群提供公平护理的关键。